Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial

Posted on by

Lancet Infectious Diseases
Mar 2022 Volume 22 Number 3 p297-426, e66-e100
https://www.thelancet.com/journals/laninf/issue/current

 

Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
Stephen E Goldstone, et al